Distributor limiting allocation of low dose Wegovy ...Middle East

The Hill - News
Distributor limiting allocation of low dose Wegovy
Distributor Novo Nordisk has decided to limit low doses of obesity medication Wegovy in the U.S. as demand outpaces supply. Novo Nordisk, a global healthcare and pharmaceutical company based in Denmark, is limiting the supply of Wegovy to conserve doses for patients already using the drug, the company said Thursday. The company is still supplying "limited quantities" of 0.25, 0.5 and 1 mg doses to wholesalers for distribution to different retail pharmacies. Wegovy was approved as a weight management treatment medication by the Food and Drug Administration in 2021. The medication belongs to a class of drugs called GLP-1 agonists that have caught on in the weight loss industr

Hence then, the article about distributor limiting allocation of low dose wegovy was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Distributor limiting allocation of low dose Wegovy )

Apple Storegoogle play

Last updated :

Also on site :



Latest News